![Aubagio Teriflunomide Injection, Sanofi Genzyme, 28 Film Coated Tablets, Rs 46872 /pack | ID: 21559365955 Aubagio Teriflunomide Injection, Sanofi Genzyme, 28 Film Coated Tablets, Rs 46872 /pack | ID: 21559365955](https://5.imimg.com/data5/WC/WO/PD/SELLER-16645300/1-500x500.jpg)
Aubagio Teriflunomide Injection, Sanofi Genzyme, 28 Film Coated Tablets, Rs 46872 /pack | ID: 21559365955
![Sanofi launches 'once daily' oral tablet 'Aubagio®', for treatment of Multiple Sclerosis in India - The Pharma Times | Pharma & Health Care News Portal Sanofi launches 'once daily' oral tablet 'Aubagio®', for treatment of Multiple Sclerosis in India - The Pharma Times | Pharma & Health Care News Portal](http://thepharmatimes.in/wp-content/uploads/2018/08/image019-1.jpg)
Sanofi launches 'once daily' oral tablet 'Aubagio®', for treatment of Multiple Sclerosis in India - The Pharma Times | Pharma & Health Care News Portal
SAŽETAK KARAKTERISTIKA LEKA 1. IME LEKA Aubagio®, 14 mg, film tablete INN: teriflunomid 2. KVALITATIVNI I KVANTITATIVNI SASTAV
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUBAGIO® safely and eff
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUBAGIO® safely and eff
![These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for oral use Initial U.S. Approval: 2012 These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for oral use Initial U.S. Approval: 2012](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=teriflunomide-03.jpg&id=522408)
These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for oral use Initial U.S. Approval: 2012
![FDA approves Genzyme's AUBAGIO® (teriflunomide) - Society for Multiple Sclerosis Patients in Pakistan FDA approves Genzyme's AUBAGIO® (teriflunomide) - Society for Multiple Sclerosis Patients in Pakistan](https://blog.smspp.org.pk/wp-content/themes/florentia/images/posts/Aubagio-tablets.jpg)